This site is intended for healthcare professionals
Anti-platelet hero
Antiplatelet therapy in ACS: Choices and Controversies

Expert Opinion

Read time: 130 mins
Last updated:8th Jul 2022
Published:22nd Apr 2022

Learn from experts in the field of cardiology, as they discuss management and treatment strategies for patients on antiplatelet therapy.

  • Listen to our podcast series for strategies to navigate treatment guidelines for dual antiplatelet therapy de-escalation
  • Delve into the evidence from clinical trials including ISAR-REACT 5, PLATO and TRITON-TIMI 38. to further inform your treatment considerations
  • Watch an informative roundtable discussion to deepen your knowledge of the key issues involved with antiplatelet therapy selection in non-ST-segment elevation acute coronary syndrome

Patient focus podcast: NSTE-ACS

In this short and informative podcast episode, Professor Robert Storey and Dr Marc P Bonaca discuss options for managing a 75 year-old female patient with a 15 year history of type 2 diabetes, who has been admitted to hospital with chest pain associated with an increase in high-sensitive troponin T. 

Discover:

  • How type 2 diabetes impacts ischaemic risk and treatment choice in acute coronary syndrome
  • Strategies for de-escalation of dual antiplatelet therapy
  • The factors that increase risk of bleeding

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

Roundtable Discussion

Follow along with four cardiology experts as they discuss some of the key issues involved with antiplatelet therapy selection in NSTE-ACS, including:

  • Recent and ongoing clinical trials
  • Updates to national and international guidelines for patient management
  • Finding the right balance between cardiovascular and bleeding risk

Access each section of the roundtable discussion below where our expert faculty discuss the nuances in clinical guidelines when considering the optimal management and treatment of non-ST-segment elevation acute coronary syndrome (NSTE-ACS), particularly when selecting antiplatelet treatments.

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

Welcome: